mRNA Vaccines and Therapeutics Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The mRNA Vaccines and Therapeutics Market size is expected to grow at an annual average of 12% during 2021-2027. Messenger ribonucleic acid (mRNA) refers to a single protein-coding gene in the genome that serves as the basis for protein synthesis within the cell. mRNA vaccines and therapeutics combine desirable immunological properties and are manufactured in the laboratory using mammalian cells. Common types of vaccines and therapeutics include self-amplifying, non-replicating, self-replicating in vivo and non-dendritic cell non-replicating mRNA in vitro. They are injected into the body to trigger virus-sensing immune sensors and produce viral antigen proteins within the cells. This helps boost the body’s immunity by improving B-cell and T-cell responses.

The following segmentation are covered in this report:

By Application

Cancer
Infectious Disease
Gene Editing
Protein Replacement

By Treatment Type

Bioengineered Vaccine
Gene Therapy
Gene Transcription
Cell Therapy
Monoclonal Antibody
Others

By Vaccine Manufacturing

In-House
Out-Sourced

Company Profile

Arcturus Therapeutics Holdings Inc.
BioNTech SE
CureVac N.V.
Daiichi Sankyo Company, Limited.
Ethris GmbH
GlaxoSmithKline plc
Gennova Biopharmaceuticals Ltd
Moderna, Inc.
Pantherna Therapeutics GmbH

 

Scope of the report

The research study analyses the MRNA Vaccines and Therapeutics Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

Market overview and growth analysis
Import and export overview
Volume analysis
Current market trends and future outlook
Market opportunistic and attractive investment segment

 

Geographic coverage

North america market size and/or volume
Latin america market size and/or volume
Europe market size and/or volume
Asia-pacific market size and/or volume
Rest of the world market size and/or volume

Key Questions Answered by mRNA Vaccines and Therapeutics Market Report

What was the MRNA Vaccines and Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
What will be the CAGR of Market during the forecast period (2021-2027)?
Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
Which manufacturer/vendor/players in the mRNA Vaccines and Therapeutics Market was the market leader in 2020?
Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.